Clinical Scorecard: Long-Term Insulin Exposure During Childhood and Adulthood and Its Impact on Retinal Microvasculature in Adulthood
At a Glance
Category
Detail
Condition
Effects of long-term endogenous insulin exposure on retinal microvasculature
Key Mechanisms
Insulin resistance and hyperinsulinemia contribute to endothelial dysfunction leading to microvascular structural changes, notably decreased retinal arteriolar diameter
Target Population
Non-diabetic individuals followed from childhood to adulthood (ages 6-49 years)
Care Setting
Longitudinal population-based cardiovascular risk study with retinal imaging in adulthood
Key Highlights
Higher cumulative insulin exposure in childhood, adulthood, and lifelong is associated with decreased retinal arteriolar diameter in adulthood.
Associations are independent of conventional cardiovascular risk factors and observed in a non-diabetic population.
Retinal microvasculature serves as a noninvasive window reflecting systemic microvascular integrity and cardiovascular risk.
Guideline-Based Recommendations
Diagnosis
Utilize retinal fundus photography to assess microvascular changes as early markers of vascular health in populations at risk for insulin resistance.
Management
Address metabolic risk factors early in life to potentially mitigate adverse microvascular changes associated with cumulative insulin exposure.
Monitoring & Follow-up
Longitudinal monitoring of insulin levels and retinal microvascular parameters may help identify early vascular alterations before clinical cardiovascular disease onset.
Risks
Chronic hyperinsulinemia, even in absence of diabetes, may contribute to microvascular narrowing and increased cardiovascular risk.
Patient & Prescribing Data
Non-diabetic individuals with varying insulin exposure from childhood through adulthood
No direct treatment data; findings emphasize importance of metabolic health maintenance to prevent microvascular impairment linked to insulin exposure.
Clinical Best Practices
Incorporate retinal microvascular assessment in cardiovascular risk evaluation for patients with insulin resistance or metabolic syndrome.
Focus on early lifestyle interventions targeting insulin resistance to preserve microvascular integrity.
Consider cumulative insulin exposure over lifespan as a factor in vascular health assessments.
by Oskari Repo, Markus Juonala, Suvi P Rovio, Juha Mykkänen, Jaakko Nevalainen, Mika Kähönen, Terho Lehtimäki, Tomi P Laitinen, Jorma Viikari, Olli Raitakari, Robyn Tapp, Katja Pahkala
